Expanding Omega-3 Market to Reach USD 13.32 Billion by 2035 as Rising Consumer Demand for Cardiovascular and Cognitive Health Fuels Growth | FMI

In the USA Omega-3 market is shifting toward pharma-grade formulations, driven by rising cardiovascular prescriptions. Leading players like KD Pharma, DSM, and BASF are expanding high-purity EPA and DHA products, with Vascepa (icosapent ethyl) setting the benchmark for ultra-refined Omega-3 concentrates in triglyceride management.

/EIN News/ -- NEWARK, Del, March 14, 2025 (GLOBE NEWSWIRE) -- The global Omega-3 market is poised for remarkable expansion, projected to surge from USD 5,785.1 million in 2025 to USD 13,323.1 million by 2035, registering an impressive CAGR of 8.7% over the forecast period. The robust market growth is driven by increasing consumer awareness of Omega-3's health benefits, particularly in cardiovascular, cognitive, and infant nutrition applications. The rising prevalence of lifestyle diseases, coupled with the global shift toward preventive healthcare, is propelling the demand for high-purity, pharmaceutical-grade Omega-3 products.

Get Ahead with Our Report: Request Your Sample Now! https://www.futuremarketinsights.com/report-sample#5245502d47422d3135393736

Key Takeaways:

• The Omega-3 market is expected to witness an 8.7% CAGR from 2025 to 2035.
• Increasing demand for pharmaceutical-grade EPA and DHA is reshaping industry standards.
• Plant-based Omega-3 alternatives such as algal DHA are gaining traction due to sustainability concerns.
• North America, Europe, and Japan are key markets for prescription-based Omega-3 formulations.
• Leading companies like DSM and Corbion are investing in microalgae production for sustainable sourcing.
  

Driving Factors of Industry Growth:

The Omega-3 industry is undergoing a dynamic transformation due to growing consumer demand for functional food products, dietary supplements, and prescription-based Omega-3 formulations. As heart disease, cognitive decline, and inflammatory disorders rise globally, Omega-3 supplements are increasingly viewed as essential preventive health solutions. Moreover, regulatory authorities such as the FDA and EU are enforcing stringent purity standards, compelling manufacturers to refine production processes to meet pharmaceutical-grade requirements. Additionally, plant-based alternatives are gaining popularity among consumers who seek sustainable and heavy-metal-free sources of Omega-3, particularly in the vegan and vegetarian segments.

Applications and Industry Trends:

The application spectrum of Omega-3 continues to expand across multiple sectors, including pharmaceuticals, functional foods, beverages, dietary supplements, and infant nutrition. In the pharmaceutical sector, high-purity Omega-3 formulations are being increasingly prescribed for hypertriglyceridemia and inflammatory conditions. Meanwhile, the functional foods and beverages segment is experiencing rapid growth as manufacturers infuse Omega-3 into dairy products, fortified drinks, and snack bars to cater to health-conscious consumers. Algal-derived Omega-3, in particular, is witnessing a surge in demand due to its sustainable production and heavy-metal-free properties, making it a preferred choice for both the food and pharmaceutical industries.

“Industry analysts highlight the accelerated shift toward prescription-based Omega-3 products as a key growth catalyst. Pharmaceutical companies are scaling up the production of EPA and DHA formulations that meet stringent regulatory approvals, enabling their entry into prescription medicine markets. Additionally, the rapid advancement in microalgae cultivation is expected to alleviate concerns over overfishing and heavy-metal contamination in traditional fish oil-based Omega-3 products, further enhancing market growth. ” - says Nandini Roy Choudhury, Client Partner at Future Market Insights

Health Benefits Driving Consumer Preference

Omega-3 fatty acids, including docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), have been widely recognized for their role in reducing inflammation, supporting heart health, and enhancing brain function. Additionally, plant-based omega-3 supplements for vegetarians, derived from algal oil and flaxseeds, are gaining traction as sustainable alternatives to marine-based sources.

Consumers are becoming increasingly health-conscious, seeking omega-3 enriched dietary supplements to improve their overall well-being. The demand for omega-3 fortified infant formula for brain development and pet nutrition products is also growing significantly.

Rising Popularity of Sustainable and Vegan Omega-3 Alternatives

With a surge in demand for sustainable sourcing of marine omega-3 oils, companies are investing in plant-based omega-3 sources such as algal oil, offering vegan-friendly and environmentally responsible alternatives. Innovations in the market include microencapsulation technology to enhance bioavailability and stability in food and beverage applications.

Detailed Market Study: Full Report and Analysis: https://www.futuremarketinsights.com/reports/omega-3-market  

Regional Analysis of the Omega-3 Market (2025–2035):

The global Omega-3 market is witnessing steady expansion, driven by rising consumer awareness about health benefits, increasing demand for functional foods, and growing applications in pharmaceuticals and nutraceuticals. Regional differences in market dynamics highlight distinct growth trends across key economies:

North America remains the dominant market for Omega-3, driven by rising awareness of heart health and an aging population increasingly adopting dietary supplements. The U.S. leads the region, with growing demand for high-purity Omega-3 products supported by FDA regulations promoting pharmaceutical-grade formulations. Europe follows closely, with stringent EU purity standards shaping the market landscape and compelling companies to optimize purification technologies. In the Asia-Pacific region, Japan stands out as a key market, particularly for prescription-based Omega-3 products, given its highly advanced healthcare system and increasing focus on preventive medicine. Meanwhile, China and India present emerging growth opportunities as consumer education on Omega-3 health benefits continues to rise.

United States: Steady Growth at 4.2% CAGR

The Omega-3 market in the United States is expected to grow at a CAGR of 4.2% from 2025 to 2035. The country is one of the largest consumers of Omega-3 supplements due to a high prevalence of lifestyle-related diseases such as cardiovascular disorders and obesity. Growing demand for EPA & DHA-rich supplements, particularly among aging populations and fitness enthusiasts, is driving market expansion. Additionally, regulatory approvals and recommendations from organizations like the American Heart Association (AHA) are further supporting market penetration.

China: Leading Growth at 5.1% CAGR

China is projected to record the highest CAGR of 5.1% in the Omega-3 market during the forecast period. The rapid growth is fueled by increasing health consciousness, government initiatives promoting functional foods and dietary supplements, and a rising aging population. The country's expanding middle-class consumer base and preference for plant-based Omega-3 alternatives are also contributing to market acceleration. Furthermore, China's strong presence in the aquaculture sector plays a crucial role in Omega-3 extraction from fish oil and algae sources.

Japan: Moderate Expansion at 2.5% CAGR

Japan’s Omega-3 market is set to grow at a CAGR of 2.5% from 2025 to 2035. Despite a relatively slower growth rate, Japan maintains a high per capita consumption of Omega-3-rich foods due to its seafood-based diet. The country’s well-established pharmaceutical sector is also a key driver, with Omega-3 being used in prescription drugs targeting heart health and cognitive functions. Additionally, the increasing shift toward plant-based Omega-3 supplements aligns with Japan’s growing demand for sustainable and eco-friendly products.

Recent Trends and Developments:

Leading players in the Omega-3 industry are ramping up efforts to enhance production capacities and improve the sustainability of their sourcing methods. DSM and Corbion, for example, are investing heavily in microalgae-based Omega-3 production, reducing reliance on traditional fish oil sources. Concurrently, fish oil suppliers are deploying advanced purification technologies to meet evolving EU and FDA purity regulations. The integration of Omega-3 in functional food products and sports nutrition is also gaining momentum, reflecting changing consumer preferences toward health-focused dietary choices.

Leading Manufacturers

• DSM Nutritional Products
• BASF SE
• Cargill, Inc.
• Corbion N.V.
• Omega Protein Corporation
• Epax Norway AS
• GC Rieber Oils
• Croda International Plc
• Archer Daniels Midland Company (ADM)
• Nordic Naturals
• KD Pharma Group
• Novonesis Group
• Golden Omega S.A
  

Explore in-depth analysis of the functional food ingredient industry: https://www.futuremarketinsights.com/industry-analysis/functional-food-ingredients

Key Segments of the Report

By Product Type:

Docosahexaenoic Acid (DHA), Eicosapentaenoic Acid (EPA), Alpha-Linolenic Acid (ALA)

By Source Type:

Fish Oil, Krill Oil, Algal Oil, Flaxseed, Chia Seeds

By Form Type:

Soft Gels/Capsules, Oil, Powder, Gummies

By Region:

Industry analysis has been carried out in key countries of North America, Latin America, Europe, Middle East and Africa, East Asia, South Asia, and Oceania

Explore FMI’s related ongoing Coverage in Food and Beverage Domain:

The Global Omega 3 Ingredients industry reached USD 5,008.0 million in 2019. Demand for Omega 3 Ingredients registered a 9.4% Compound Annual Growth Rate from 2019 to 2023, indicating that the global industry would reach USD 8,088.2 million in 2024.

The global microencapsulated omega-3 powders market size is likely to exceed USD 17.4 Billion in 2032 and exhibit steady growth at a CAGR of 8.2% in the forecast period from 2022 to 2032. Increasing product consumption on the back of changing dietary habits and rising prevalence of cardiovascular diseases is set to push growth.

The global Omega-3 Concentrates market is estimated to be worth USD 2.9 billion in 2024 and is projected to reach a value of USD 5.7 Billion by 2034, expanding at a CAGR of 7.0% over the assessment period of 2024 to 2034

The Algae Omega industry globally were valued at USD 882.0 million. It was also determined to have historical growth from 2019 to 2023 with a CAGR of 5.3%, therefore its revenue figures are projected to hit USD 1,151.5 million by 2024. Within the years to come, it is expected that the global statistics will go up by 3.7% CAGR which would amount to USD 1,656.0 million by the year 2034.

The algae omega market in Asia-Pacific countries started attaining sales figures in 2019, the industry reached an annual figure of USD 273.4 million. With a historical CAGR of 5.3% from 2020 to 2024, that revenue in Asia-Pacific is anticipated to rise to USD 356.9 million by 2025 and eventually to USD 513.3 million by 2035 with a CAGR of 3.4%.

The Europe algae omega market is positioned for vigorous expansion in the forecast period 2025 to 2035. By the year of 2025, algae omega is likely to increase in value up to USD 403.0 million and over the coming 10 years is estimated to grow at the annual rate of 4.4%.

The revenue figures are projected to hit USD 57.6 million by 2025. Within the years to come, it is expected that the UK Algae Omega Industry statistics will go up by 7.2% CAGR which would amount to USD 115.9 million by the year 2035.

The global omega-3 pet supplement industry is estimated to be valued at USD 1,280.7 million in 2024 and further increase at a CAGR of 7.9% over the assessment period. By 2034, global sales of omega-3 pet supplements are projected to total USD 2,292.4 million by 2034, driven by rising emphasis on animal health.

The freeze-dried pet food market share is estimated to show consistent growth throughout the forecast period, expanding at a CAGR of 5%. The freeze-dried pet food market value is expected to expand from USD 18,250.07 million in 2024 to USD 29,589.7 million by 2034.

The global dehydrated garlic market is estimated to register a jump with a CAGR of 5.70% to reach USD 12.21 billion. The forecasted market size of the subject market by 2024 is USD 7.02 billion. Various driving forces influence the market’s growth.

About Future Market Insights (FMI) 

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries. 

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube